Mirum Pharmaceuticalsincis A Biopharmaceutical Company Based In Foster Citycaliforniafocused On Developing Therapies For Rare Liver Diseasesfounded In 2018Mirum Aims To Transform The Treatment Landscape For These Conditions By Creating Safe And Effective Medicinesthe Company S Name Reflects Its Mission To Deliver Remarkable Therapies For Individuals Living With Rare Diseases Mirum Has Three Approved Medicineslivmarlia Maralixibatoral Solutioncholbama Cholic Acidcapsulesand Chenodala Chenodioltabletslivmarliais Specifically Approved For Treating Cholestatic Pruritus In Patients With Alagille Syndrome And Primary Familial Intrahepatic Cholestasischolbamaaddresses Bile Acid Synthesis Disorderswhile Chenodalais Used For The Dissolution Of Cholesterol Gallstones The Company Is Dedicated To Supporting Patients And Families Affected By Rare Liver Diseasesemphasizing Community Engagement And Awarenessrecentlymirum Expanded Its Capabilities By Acquiring Assets From Travere Therapeuticsfurther Enhancing Its Commitment To Addressing The Needs Of Those With Rare Diseases
No conferences found for this company.
| Company Name | Mirum Pharmaceuticals Inc |
| Country |
United States
|
| Address | N/A |
| Telephone | N/A |
| N/A |
